2.24
price up icon6.67%   0.14
pre-market  Vorhandelsmarkt:  2.56   0.32   +14.29%
loading
Schlusskurs vom Vortag:
$2.10
Offen:
$2.13
24-Stunden-Volumen:
530.41K
Relative Volume:
0.60
Marktkapitalisierung:
$238.37M
Einnahmen:
$45.44M
Nettoeinkommen (Verlust:
$-35.43M
KGV:
-6.5882
EPS:
-0.34
Netto-Cashflow:
$-25.39M
1W Leistung:
+6.16%
1M Leistung:
+9.80%
6M Leistung:
-55.73%
1J Leistung:
-50.33%
1-Tages-Spanne:
Value
$2.12
$2.295
1-Wochen-Bereich:
Value
$2.02
$2.295
52-Wochen-Spanne:
Value
$2.00
$5.20

Maxcyte Inc Stock (MXCT) Company Profile

Name
Firmenname
Maxcyte Inc
Name
Telefon
301-517-5556
Name
Adresse
9713 KEY WEST AVENUE,, ROCKVILLE
Name
Mitarbeiter
114
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
MXCT's Discussions on Twitter

Vergleichen Sie MXCT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
MXCT
Maxcyte Inc
2.24 224.33M 45.44M -35.43M -25.39M -0.34
Medical Devices icon
ABT
Abbott Laboratories
125.73 228.77B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.16 153.09B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
395.15 149.27B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.65 114.31B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.30 45.06B 5.54B 4.18B 623.10M 7.00

Maxcyte Inc Stock (MXCT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-22 Eingeleitet Stephens Overweight
2023-11-29 Eingeleitet Craig Hallum Buy
2021-10-15 Fortgesetzt Cowen Outperform
2021-08-24 Eingeleitet BTIG Research Buy
2021-08-24 Eingeleitet Cowen Outperform
2021-08-24 Eingeleitet Stephens Overweight
2021-08-24 Eingeleitet Stifel Buy
2021-08-24 Eingeleitet Wedbush Outperform
2021-08-24 Eingeleitet William Blair Outperform
Alle ansehen

Maxcyte Inc Aktie (MXCT) Neueste Nachrichten

pulisher
04:24 AM

Is MaxCyte Inc. a good long term investmentPhenomenal capital appreciation - Autocar Professional

04:24 AM
pulisher
02:30 AM

What analysts say about MaxCyte Inc. stockExplosive earning power - Autocar Professional

02:30 AM
pulisher
Jul 22, 2025

What drives MaxCyte Inc. stock priceJaw-dropping returns - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

MaxCyte Inc. Stock Analysis and ForecastMarket-leading profit generation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

Why MaxCyte Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes MaxCyte Inc. stock price move sharplySwing Trade Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

IWN ETF Implied Analyst Target Price: $198.15 - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

How MaxCyte Inc. stock performs during market volatilityDaily Swing Candidates - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times

Jul 09, 2025
pulisher
Jul 09, 2025

MaxCyte, Inc. to Release Second Quarter 2025 Financial Results on August 6th - Nasdaq

Jul 09, 2025
pulisher
Jul 02, 2025

PHC announces exclusive distribution of MaxCyte ExPERT platform in Japan - BioSpectrum Asia

Jul 02, 2025
pulisher
Jul 01, 2025

PHC TO EXCLUSIVELY DISTRIBUTE MAXCYTE CELL ENGINEERING PLATFORM IN JAPAN - bernama

Jul 01, 2025
pulisher
Jul 01, 2025

Business Wire - JIJI PRESS

Jul 01, 2025
pulisher
Jul 01, 2025

PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan - Business Wire

Jul 01, 2025
pulisher
Jun 26, 2025

MaxCyte Cancels AIM Market Trading for Common Stock - TipRanks

Jun 26, 2025
pulisher
Jun 25, 2025

MaxCyte shares trading for last time in London - Sharecast.com

Jun 25, 2025
pulisher
Jun 23, 2025

Moving Gene Editing Advances Into the Clinic - the-scientist.com

Jun 23, 2025
pulisher
Jun 19, 2025

MaxCyte stockholders approve AIM delisting, company to trade only on Nasdaq - Investing.com

Jun 19, 2025
pulisher
Jun 18, 2025

MaxCyte Shareholders Approve Equity Plan Amendment - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

MaxCyte shareholders approve equity plan expansion, AIM delisting - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Analyzing Ratios: MaxCyte Inc (MXCT)’s Financial Story Unveiled - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

MaxCyte shareholders approve equity plan expansion, AIM delisting By Investing.com - Investing.com UK

Jun 18, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Sells 82,134 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte & Ori Biotech Integrate Platforms for Efficient Manufacturing - Contract Pharma

Jun 11, 2025
pulisher
Jun 11, 2025

Market news - investments.halifax.co.uk

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte enters collaboration with Ori Biotech - Sharecast.com

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte (MXCT) Partners with Ori Biotech to Boost Cell Therapy Manufacturing | MXCT Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Forge Strategic Partnership to Enhance Cell Therapy Manufacturing Efficiency - Nasdaq

Jun 11, 2025

Finanzdaten der Maxcyte Inc-Aktie (MXCT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$285.57
price up icon 1.64%
medical_devices STE
$223.69
price up icon 0.47%
medical_devices PHG
$25.02
price up icon 1.96%
$85.12
price up icon 1.30%
$76.49
price up icon 3.14%
medical_devices EW
$76.30
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):